HEALTHDAILY MAIL
Ozempic and Wegovy can lead to devastating muscle and bone loss... now experts reveal exactly how to fight it
Ozempic and Wegovy, GLP-1 receptor agonists, have been linked to significant muscle and bone loss in patients. Experts now outline strategies to mitigate these effects, including dietary adjustments, strength training, and monitoring calcium/vitamin D levels.
Mentioned
Related Signal
Adjacent reporting
- Ozempic and Wegovy can lead to devastating muscle and bone loss... now experts reveal exactly how to fight it
- Scientists may have found a way to keep your bones strong for life
- Calcium and Vitamin D supplements taken by millions DON'T prevent painful bone fractures and falls, study finds - BMJ
- New obesity treatment may help preserve muscle during weight loss
- Scientists discover strange link between vitamin D and pain
- The hidden tradeoff behind today’s most popular weight loss drugs